CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $227,446 | -54.3% | 46,323 | 0.0% | 0.03% | -56.1% |
| Q4 2022 | $497,509 | +14.6% | 46,323 | 0.0% | 0.07% | +1.5% |
| Q3 2022 | $434,000 | +34.0% | 46,323 | +30.4% | 0.06% | +44.4% |
| Q2 2022 | $324,000 | -25.0% | 35,522 | 0.0% | 0.04% | -11.8% |
| Q1 2022 | $432,000 | +17.7% | 35,522 | +17.8% | 0.05% | +34.2% |
| Q4 2021 | $367,000 | -21.2% | 30,149 | 0.0% | 0.04% | -29.6% |
| Q3 2021 | $466,000 | +8.4% | 30,149 | 0.0% | 0.05% | +5.9% |
| Q2 2021 | $430,000 | -34.4% | 30,149 | 0.0% | 0.05% | -38.6% |
| Q1 2021 | $655,000 | +133.9% | 30,149 | +62.7% | 0.08% | +124.3% |
| Q4 2020 | $280,000 | – | 18,531 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |